Cost of pharmaceutical benefits
Mackereth, M.B.
New Zealand Medical Journal 101(849): 460-461
1988
ISSN/ISBN: 0028-8446 PMID: 3399187 Document Number: 318233
Document emailed within 1 workday
Related Documents
Neaverson, M.A. 1979: Cost of pharmaceutical benefits Medical Journal of Australia 2(9): 483Di Pasquale, C. 1983: Various methods for community fluoridation--the situation in Africa. (A comparative study on cost benefits and cost effectiveness.) Odonto-Stomatologie Tropicale 6(1): 7-18
Feros, P.M. 1986: Pharmaceutical benefits scheme Medical Journal of Australia 145(8): 427
Louis, W.J.; O'Callaghan, C.J.; Krum, H.; Mander, A.G.; Louis, E.S. 1994: Pharmaceutical Benefits Scheme Medical Journal of Australia 161(2): 174
Henry, D.A.; Birkett, D.J. 2001: Changes to the Pharmaceutical Benefits Advisory Committee Medical Journal of Australia 174(5): 209-210
Baichwal, R.S. 1988: Benefits of biotechnology to pharmaceutical industry Hindustan Antibiotics Bulletin 30(3-4): 51-53
Duckett, S.J. 2004: Drug policy down under: Australia's pharmaceutical benefits scheme Health Care Financing Review 25(3): 55-67
Miroshnichenko, I.V.; Krasavin, K.D.; Malykh, A.B.; Gaĭnov, V.S.; Popov, A.P.; Pastukhov, A.G. 2012: Improvement of pharmaceutical benefits for military retirees in outpatient care Voenno-Meditsinskii Zhurnal 333(6): 4-11
Jerger, J. 2001: Are the benefits worth the cost? Journal of the American Academy of Audiology 12(8): 4p Preceding 383
Nelson, A.A.; Tindall, W.N.; Gourley, D.R.; Arrigo, J.; Anderson, R.J. 1976: Cost of comprehensive pharmaceutical services in a 45-bed rural hospital American Journal of Hospital Pharmacy 33(11): 1149-1153
Benjamin, D.M. 1986: Managing the cost of health care benefits Topics in Health Care Financing 12(4): 39-45
Kopf, R. 1980: Drug legislation 1976: cost analysis for the pharmaceutical industry Der Internist 21(6): 333-338
Johnston, M.V.; Keith, R.A. 1983: Cost-benefits of medical rehabilitation: review and critique Archives of Physical Medicine and Rehabilitation 64(4): 147-154
Henry, D.A.; Cully, L.R.; Grigson, T.; Lee, C. 1991: Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee Medical Journal of Australia 155(5): 332-336
Guibal, A. 2015: Beyond Biopsy: the Cost Benefits of ShearWave Elastography for Liver Diagnosis Radiology Management 37(4): 13-15
Rybak, M.J.; Allen, R.; Arnow, P.; Craven, P.C.; Freeman, R.; Grüneberg, R.N.; Korin, J.; Nightingale, C.H.; Rubinstein, E.; Schaison, G.S. 1993: Roundtable discussion. Maximizing potential cost benefits of teicoplanin through appropriate usage Hospital Formulary 28 Suppl. 1: 62-68
Benko, L.B. 2004: Stripping away mandates. States allow lower-cost policies with fewer benefits Modern Healthcare 34(14): 14
Emery, D.W.; De Brantes, F. 2015: Curing an ill healthcare system: transparent multilateral benefits, cost, and quality Healthcare Financial Management: Journal of the Healthcare Financial Management Association 69(2): 80-83
Phothong, N.; Akaraviputh, T.; Chinswangwatanakul, V.; Methasate, A.; Trakarnsanga, A. 2015: Cost-Effective and Potential Benefits in Three-Port Hand-Assisted Laparoscopic Sigmoidectomy Journal of the Medical Association of Thailand 98(9): 864-870
Larsen, J.L.; Duckworth, W.C.; Stratta, R.J. 1994: Pancreas transplantation for type i diabetes mellitus. do the benefits offset the risks and cost? Postgraduate Medicine 96(3): 105-111